Morgan Stanley
LFMD icon

Morgan Stanley’s LifeMD LFMD Stock Holding History

Morgan Stanley’s Portfolio LFMD Stock Details LFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.67M Buy
404,121
+39,632
+11% +$175K ﹤0.01% 4943
2026
Q1 		$1.32M Buy
364,489
+38,284
+12% +$132K ﹤0.01% 5009
2025
Q4 		$1.11M Sell
326,205
-649,552
-67% -$3.15M ﹤0.01% 5131
2025
Q3 		$6.63M Sell
975,757
-617,525
-39% -$5.1M ﹤0.01% 3917
2025
Q2 		$21.7M Buy
1,593,282
+847,262
+114% +$8M ﹤0.01% 2720
2025
Q1 		$4.06M Buy
746,020
+327,330
+78% +$1.86M ﹤0.01% 4100
2024
Q4 		$2.07M Buy
418,690
+80,039
+24% +$420K ﹤0.01% 4674
2024
Q3 		$1.77M Sell
338,651
-287,843
-46% -$1.66M ﹤0.01% 4728
2024
Q2 		$4.3M Buy
626,494
+40,432
+7% +$370K ﹤0.01% 4007
2024
Q1 		$6.02M Buy
586,062
+240,503
+70% +$1.78M ﹤0.01% 3770
2023
Q4 		$2.86M Buy
345,559
+197,785
+134% +$1.42M ﹤0.01% 4289
2023
Q3 		$924K Buy
147,774
+122,140
+476% +$529K ﹤0.01% 4846
2023
Q2 		$112K Buy
25,634
+21,500
+520% +$47.7K ﹤0.01% 5901
2023
Q1 		$7.03K Sell
4,134
-3,257
-44% -$5.75K ﹤0.01% 6981
2022
Q4 		$14.3K Sell
7,391
-5,139
-41% -$11.5K ﹤0.01% 6811
2022
Q3 		$24K Sell
12,530
-10,830
-46% -$25.8K ﹤0.01% 6714
2022
Q2 		$48K Sell
23,360
-5,976
-20% -$14.8K ﹤0.01% 6631
2022
Q1 		$103K Sell
29,336
-18,205
-38% -$64.6K ﹤0.01% 6287
2021
Q4 		$184K Sell
47,541
-18,795
-28% -$88.8K ﹤0.01% 6119
2021
Q3 		$412K Buy
66,336
+33,424
+102% +$285K ﹤0.01% 5611
2021
Q2 		$387K Buy
32,912
+16,895
+105% +$194K ﹤0.01% 5684
2021
Q1 		$253K Buy
16,017
+8,134
+103% +$146K ﹤0.01% 5521
2020
Q4 		$51K Buy
+7,883
New +$57.8K ﹤0.01% 6155

Other funds holding LFMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1.16B AUM 53.61% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Morgan Stanley's LFMD Position: Q2 2026 in Review

Morgan Stanley increased its LifeMD (LFMD) stake by 11% in Q2 2026, buying an estimated $175K and bringing the position to 404,121 shares worth $1.67M. The position accounts for ﹤0.01% of the portfolio, ranked #4943.

Morgan Stanley first reported a position in LFMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $21.7M in Q2 2025. 116 funds tracked by Wall St. Rank hold LFMD as of Q2 2026.

  • Morgan Stanley held 404,121 shares of LifeMD worth $1.67M as of Q2 2026.
  • Morgan Stanley bought 39,632 LifeMD shares in Q2 2026, an estimated $175K.
  • LifeMD made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4943 holding.
  • Morgan Stanley first reported a position in LifeMD in Q4 2020 and has held it in 23 quarters since.
  • Morgan Stanley's LifeMD position peaked at $21.7M in Q2 2025.
  • 116 funds tracked by Wall St. Rank held LifeMD as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.